+ Follow

Sunny Fang

,

362 Presentations
Rejoint 05/21/2020

Télécharger

Cyclic Peptides Current Status & Future Prospects

Cyclic Peptides Current Status & Future Prospects

23 vues

Development of Current Four Generation ADCs And Next Generation ADCs

Development of Current Four Generation ADCs And Next Generation ADCs

36 vues

Antibody–Oligonucleotide Conjugates (AOCs) in Clinical Trials

Antibody–Oligonucleotide Conjugates (AOCs) in Clinical Trials

26 vues

Alzheimer's Disease Drug Development Aducanumab, Lecanemab & Donanemab

Alzheimer's Disease Drug Development Aducanumab, Lecanemab & Donanemab

34 vues

Claudin6 (CLDN6) A Emerging Target For Solid Tumor

Claudin6 (CLDN6) A Emerging Target For Solid Tumor

14 vues

ROR1 ADCs in Clinical Trials MK-2140, NBE-002 & CS5001

ROR1 ADCs in Clinical Trials MK-2140, NBE-002 & CS5001

39 vues

Sales of ADC Drugs From 2020 To 2023

Sales of ADC Drugs From 2020 To 2023

24 vues

Summary of Targeted Protein Degradation in Clinical Trials

Summary of Targeted Protein Degradation in Clinical Trials

14 vues

Summary of Targeted Protein Degradation in Clinical Trials

Summary of Targeted Protein Degradation in Clinical Trials

12 vues

Overview of New Targets For Anti-tumor Drugs

Overview of New Targets For Anti-tumor Drugs

30 vues

The Role of Helper Lipids in Lipid Nanoparticles

The Role of Helper Lipids in Lipid Nanoparticles

25 vues

Biopharma PEG can provide plant-derived cholesterol, DSPE and PEG Lipids for LNP

Biopharma PEG can provide plant-derived cholesterol, DSPE and PEG Lipids for LNP

28 vues

Cleavable Linkers Used In ADC Development

Cleavable Linkers Used In ADC Development

109 vues

The Role of Four Lipid Components Of LNPs

The Role of Four Lipid Components Of LNPs

111 vues

Trophoblast Glycoprotein (TPGB5T4) A New Target For ADC Drugs

Trophoblast Glycoprotein (TPGB5T4) A New Target For ADC Drugs

97 vues

PEG‐rhG‐CSF for Neutropenia

PEG‐rhG‐CSF for Neutropenia

82 vues